- Home
-
- WELCOME
- StrategicRISK is an international award-winning publication and information source for corporate risk and insurance managers. We focus on promoting the benefits of risk management and supporting risk managers and the risk community to drive risk maturity.
-
- CONTRIBUTE
- Are you a risk professional and feel passionately about a risk management issue or industry challenge? Do you want to share your views? Then get in contact and join us as we promote excellence in risk management.
- Click here to contact us
-
- ACCESS
- You can get full access to our latest content and archive right now by registering online. As a registered user you’ll receive online access to our full archive, exclusive content, weekly news alerts and, if you are a corporate risk manager, complementary invitations to our conferences and events held around the world.
- Click here to register
-
- COVID-19
- Sections
- Topics
- Editions
- Events
-
- REGISTER
- Our event formula is simple, present engaging thought provoking speakers and content exclusively for risk managers. StrategicRISK events are free to attend and by invitation only for corporate risk and insurance managers.
- Click here to register
-
- For further information about getting involved with StrategicRISK events please contact Adam Jordan at adam.jordan@nqsm.com
-
- UPCOMING EVENTS
- Risk Forum UK, London
- Risk Forum Europe, Paris
- Risk Forum Middle East, Dubai
- Risk Forum APAC, Singapore
- Risk Forum Malaysia, Kuala Lumpur
- Risk Forum Australia, Melbourne
- Risk Forum Hong Kong
-
- More navigation items
Brexit chaos spells trouble for risk managers
As the Brexit deadline nears, uncertainty prevails after British MPs rejected the prime minister’s deal – twice. StrategicRISK gathers the reaction of European risk managers, including the chief risk officer of French pharmaceutical company, Ipsen, who has prepared the business for a ‘hard Brexit’. Sara Benwell reports
For continued access to free content, you need to register.
(If you’re already registered, please sign in here.)
Register to continue reading
We’re glad you’re finding our content useful. For continued access to free content on the site please take a few moments to register, or sign in if you have already registered.
- Breaking industry news as it happens
- Expert analysis and comment from industry leaders
- Unlimited access to all stories, including premium content
- Sign up for newsletters
- Create a profile and post comments on stories